The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study
暂无分享,去创建一个
Paolo Barone | Graeme MacPhee | Kazuo Abe | Fabrizio Stocchi | Sue Thomas | Alison Forbes | A. Forbes | K. Abe | K. Chaudhuri | A. Schapira | W. Ondo | P. Barone | P. Martínez-Martín | K. Sethi | F. Stocchi | D. Rye | W. Olanow | P. Odin | Y. Naidu | S. Tluk | G. Macphee | Kieran Breen | D. Macmahon | Y. Tsuboi | Yoshio Tsuboi | Doug MacMahon | Annette Hand | M. Rabey | Kapil Sethi | Kallol Ray Chaudhuri | Pablo Martinez‐Martin | Per Odin | Richard G. Brown | Martin Rabey | William Ondo | David Rye | Susanne Tluk | Adrian J. Williams | Yogini Naidu | K. Breen | Warren Olanow | Annette Hand | Anthony H.V. Schapira | Sue Thomas | A. Williams | Richard G. Brown | Sue A. Thomas | D. MacMahon
[1] D. Streiner,et al. Health measurement scales , 2008 .
[2] E. Lai,et al. Non-motor Symptoms of Parkinson's Disease , 2007 .
[3] J. Jankovic,et al. Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan , 2007, Movement disorders : official journal of the Movement Disorder Society.
[4] T. Mills,et al. Measuring Health: A Guide to Rating Scales and Questionnaires , 2006 .
[5] Paolo Barone,et al. International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study , 2006, Movement disorders : official journal of the Movement Disorder Society.
[6] K. Chaudhuri,et al. I.P2 Prevalence of non motor symptoms in Parkinson's Disease: An international survey using NMSQuest in 525 patients , 2006 .
[7] J. Benito-León,et al. Impact of Fatigue in Parkinson’s Disease: The Fatigue Impact Scale for Daily Use (D-FIS) , 2006, Quality of Life Research.
[8] K. Chaudhuri,et al. Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.
[9] A. Lang. Treatment of progressive supranuclear palsy and corticobasal degeneration , 2005, Movement disorders : official journal of the Movement Disorder Society.
[10] M Knapp,et al. Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. , 2005, Health technology assessment.
[11] L. Rajmil. Health measurement scales. A practical guide to their development and use, 3rd ed , 2005 .
[12] M. Hely,et al. Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years , 2005, Movement disorders : official journal of the Movement Disorder Society.
[13] J. Fisk,et al. A comparison of health utility measures for the evaluation of multiple sclerosis treatments , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[14] Johan Marinus,et al. Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA‐AUT , 2004, Movement disorders : official journal of the Movement Disorder Society.
[15] A. Stiggelbout,et al. Assessing comorbidity in patients with Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.
[16] H. Singer,et al. Anti‐basal ganglia antibodies in PANDAS , 2004, Movement disorders : official journal of the Movement Disorder Society.
[17] R. Brown,et al. The assessment of fatigue: a practical guide for clinicians and researchers. , 2004, Journal of psychosomatic research.
[18] Gert Jan Lammers,et al. Assessment of sleep and sleepiness in Parkinson disease. , 2003, Sleep.
[19] A M Stiggelbout,et al. Assessment of cognition in Parkinson’s disease , 2003, Neurology.
[20] Jeremy Holmes,et al. Direct economic impact of Parkinson's disease: A research survey in the United Kingdom , 2003, Movement disorders : official journal of the Movement Disorder Society.
[21] G. Norman,et al. Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.
[22] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[23] Ulf Persson,et al. Resource use and costs in a Swedish cohort of patients with Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.
[24] A. Stiggelbout,et al. Evaluation of the Hospital Anxiety and Depression Scale in Patients With Parkinson's Disease , 2002, Clinical neuropharmacology.
[25] Kathleenl N. Lohr,et al. Assessing health status and quality-of-life instruments: Attributes and review criteria , 2002, Quality of Life Research.
[26] D. Royall,et al. The FAB: A frontal assessment battery at bedside , 2001, Neurology.
[27] J. Larsen,et al. Health related quality of life in Parkinson's disease: a prospective longitudinal study , 2000, Journal of neurology, neurosurgery, and psychiatry.
[28] J. Larsen,et al. Clinical problems in non‐fluctuating patients with Parkinson's disease: A community‐based study , 2000, Movement disorders : official journal of the Movement Disorder Society.
[29] Marjan Jahanshahi,et al. What contributes to quality of life in patients with Parkinson's disease? , 2000, Journal of neurology, neurosurgery, and psychiatry.
[30] P. Fayers,et al. Quality of Life: Assessment, Analysis, and Interpretation , 2000 .
[31] L. Findley,et al. Quality of life in Parkinson's disease , 1999, International journal of clinical practice.
[32] D J Hand,et al. Clinical impact versus factor analysis for quality of life questionnaire construction. , 1998, Journal of clinical epidemiology.
[33] C. Clarke,et al. QUALITY OF LIFE AND CARE IN PARKINSON'S DISEASE , 1995, The British journal of clinical practice.
[34] C. McHorney,et al. Individual-patient monitoring in clinical practice: are available health status surveys adequate? , 1995, Quality of Life Research.
[35] R. Hays,et al. Psychometric considerations in evaluating health-related quality of life measures , 1993, Quality of Life Research.
[36] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[37] Sati Mazumdar,et al. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale , 1992, Psychiatry Research.
[38] I. McDowell,et al. Measuring health: A guide to rating scales and questionnaires, 3rd ed. , 2006 .
[39] J. Ware,et al. Measuring Components of Children's Health Status , 1979, Medical care.
[40] B. Linn,et al. CUMULATIVE ILLNESS RATING SCALE , 1968, Journal of the American Geriatrics Society.
[41] C. Terwee,et al. Quality criteria were proposed for measurement properties of health status questionnaires. , 2007, Journal of clinical epidemiology.
[42] S. Leurgans,et al. Addressing non-motor impairments in Parkinson's disease: The new version of the UPDRS , 2005 .
[43] R. Hays,et al. Estimating clinically significant differences in quality of life outcomes , 2004, Quality of Life Research.
[44] W. Weiner,et al. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. , 2002, Parkinsonism & related disorders.
[45] Fabrizio Stocchi,et al. Factors impacting on quality of life in Parkinson's disease: Results from an international survey , 2002, Movement disorders : official journal of the Movement Disorder Society.
[46] A. Bonnet,et al. [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.
[47] Irene Litvan,et al. A frontal assessment battery at bedside , 2000 .
[48] R. Fitzpatrick,et al. The PDQ-8: Development and validation of a short-form parkinson's disease questionnaire , 1997 .
[49] S. Fahn. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .
[50] G. Huston. The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.
[51] C. Marsden,et al. Recent Developments in Parkinson's Disease , 1986 .
[52] B. Djahanguiri,et al. The prevention of acute gastric ulcer in the rat by alpha-methyldopa. , 1967, Medicina et pharmacologia experimentalis. International journal of experimental medicine.